0001549595-12-000001.txt : 20120515
0001549595-12-000001.hdr.sgml : 20120515
20120515170407
ACCESSION NUMBER: 0001549595-12-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20120515
DATE AS OF CHANGE: 20120515
EFFECTIVENESS DATE: 20120515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nurix, Inc.
CENTRAL INDEX KEY: 0001549595
IRS NUMBER: 270838048
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-178327
FILM NUMBER: 12845787
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: (415) 865-2057
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
D
1
primary_doc.xml
X0705
D
LIVE
0001549595
Nurix, Inc.
1700 OWENS STREET, SUITE 500
SAN FRANCISCO
CA
CALIFORNIA
94158
(415) 865-2057
DELAWARE
Kura Therapeutics, Inc.
None
Corporation
true
2009
Timothy
Kutzkey
1700 Owens St.., Suite 500
San Francisco
CA
CALIFORNIA
94158
Executive Officer
Director
David
Goeddel
1700 Owens St.., Suite 500
San Francisco
CA
CALIFORNIA
94158
Director
Other
Decline to Disclose
- 06
false
2012-04-30
false
true
false
0
3100000
3100000
0
Porceeds are to be used for working capital.
false
4
0
0
0
false
Nurix, Inc.
/s/Michael E. Tenta
Michael E. Tenta
Secretary
2012-05-15